Shares of Ondine Biomedical Inc. (LON:OBI – Get Free Report) were up 2% on Monday . The company traded as high as GBX 8 ($0.10) and last traded at GBX 7.75 ($0.10). Approximately 250,062 shares traded hands during trading, a decline of 21% from the average daily volume of 317,272 shares. The stock had previously closed at GBX 7.60 ($0.10).
Ondine Biomedical Trading Up 2.0 %
The stock has a 50 day moving average of GBX 7.66 and a 200-day moving average of GBX 7.52. The company has a market capitalization of £21.49 million, a P/E ratio of -258.33 and a beta of 0.10. The company has a current ratio of 0.80, a quick ratio of 8.26 and a debt-to-equity ratio of 1,847.37.
About Ondine Biomedical
Ondine Biomedical Inc, a Life sciences company, engages in the research, development, and commercialization of antimicrobial photodisinfection therapies in Canada and internationally. Its product platform is Photodisinfection, a topical light-based antimicrobial technology that eliminates harmful pathogens.
See Also
- Five stocks we like better than Ondine Biomedical
- Want to Profit on the Downtrend? Downtrends, Explained.
- Semtech Stock Climbs as AI Boom Drives Turnaround Success
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- 3 Companies Leading the Way With Aggressive Stock Buybacks
- EV Stocks and How to Profit from Them
- Is It Time to Buy Nuclear Energy Stocks After the Latest Dip?
Receive News & Ratings for Ondine Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ondine Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
